Oculentis Compensation Claims

About the Oculentis recall

The Oculentis recall for the Lentis foldable Intraocular lenses initially stemmed from 2014 with an updated Field Safety Notice issued in 2017.

The Field Safety Notice confirms that surface calcification could lead to opacification, which could be the result of “phosphate remnants originating from a detergent previously used in the cleaning process of the IOL (intraocular lense).”

Oculentis has stopped using the cleaning detergent that may have been causing the Oculentis opacification problems. Oculentis accepted that the “opacification may compromise the optical transparency of the IOL in time, potentially leading to a slow reduction in the patient's visual acuity.”

Our Group Action Lawyers are satisfied that there is a case to answer for anyone who is suffering from the Oculentis opacification problems.

We have therefore agreed to offer No Win, No Fee representation for victims who initiate their compensation claim with us.

As with the other 40+ group actions we're fighting for justice in - and the actions we have settled - we've assessed the case and we consider there are grounds to make a claim. As big believers in access to justice, we are prepared to take cases forward on the basis that we can write off our legal fees if the case isn't successful where a Claimant agrees to, and abides by, our terms and conditions.

In other medical actions, we've had to write off legal fees as a result of problems obtaining compensation when the Defendant is uninsured and has gone into liquidation. We stick to our promises; even when a case should have won, and the issue was the Defendant escaping justice by closing their business.